Search | TVST | ARVO Journals

Showing 1 – 16 of 16

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2024

Can modifiable behavioral factors be identified to increase activation in patients with glaucoma?

Alan R Morse; Lisa A Hark; Prakash Gorroochurn; Rebecca Rojas; William H Seiple; Aakriti Garg Shukla; Yujia Wang; Stefania Maruri; Desiree Henriquez; Noga Harizman; Qing Wang; Jeffrey M Liebmann; George A. Cioffi

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):4044.

Glaucoma January 2024

Detecting Established Glaucoma Using OCT Alone: Utilizing an OCT Reading Center in a Real-World Clinical Setting

PDF

Ari Leshno; Emmanouil Tsamis; Sitara Hirji; Gabriel A. Gomide; Noga Harizman; Carlos Gustavo De Moraes; Aakriti Garg Shukla; George A. Cioffi; Donald C. Hood; Jeffrey M. Liebmann
TAGS: diagnostic imaging, glaucoma, reading (activity), eye
Trans. Vis. Sci. Tech.. 2024; 13(1):4. https://doi.org/10.1167/tvst.13.1.4

ARVO Annual Meeting Abstract June 2023

Manhattan Vision Screening and Follow-up Study (NYC-SIGHT) Cluster-Randomized Clinical Trial: Subanalysis of Falls Risk

Lisa A. Hark; Daniel Diamond; Yujia Wang; Stefania C Maruri; Desiree R. Henriquez; Phyllis Simon; Jason D. Horowitz; Lisa Park; Qing Wang; David S. Friedman; Jeffrey M Liebmann; George Cioffi; Noga Harizman

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):2482.

ARVO Annual Meeting Abstract June 2023

A systematic OCT-based approach can improve ophthalmology residents’ performance in glaucoma detection

Sitara Hanif Hirji; Ari Leshno; Emmanouil Tsamis; Alexis Kassotis; Anna J Sun; Gabriel Gomide; Sol La Bruna; Noga Harizman; George Cioffi; Jeffrey M Liebmann; Donald C Hood

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):2015.

ARVO Annual Meeting Abstract June 2023

Manhattan Vision Screening and Follow-up Study (NYC-SIGHT) Cluster-Randomized Clinical Trial: Subanalysis of Glaucoma Suspect Findings

Stefania C Maruri; Qing Wang; Ives Valenzuela; Noga Harizman; Prakash Gorroochurn; Desiree R. Henriquez; Daniel Diamond; Lisa Park; Jason D. Horowitz; James D. Auran; David S. Friedman; C. Gustavo De Moraes; George Cioffi; Jeffrey M Liebmann; Lisa A. Hark

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):126.

ARVO Annual Meeting Abstract June 2023

24-2 Visual Field Progression Rates Better Correlate with GCL than RNFL Rate of Change in Glaucoma

Xin Xin Xing; Ari Leshno; Emmanouil Tsamis; Aakriti Garg Shukla; Qing Wang; Noga Harizman; George A Cioffi; Sitara Hanif Hirji; C. Gustavo De Moraes; Jeffrey M Liebmann

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):2010.

ARVO Annual Meeting Abstract June 2023

Manhattan Vision Screening and Follow-up Study (NYC-SIGHT) Cluster-Randomized Clinical Trial: Smartphone Ownership to Assess Digital Health Equity

Alexa M. Kaminsky; Prakash Gorroochurn; Stefania C Maruri; Desiree R. Henriquez; Jason D. Horowitz; Lisa Park; Qing Wang; Daniel Diamond; Noga Harizman; James D. Auran; Tarun Sharma; Jeffrey M Liebmann; George Cioffi; Lisa A. Hark

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):3071.

ARVO Annual Meeting Abstract June 2023

Manhattan Vision Screening and Follow-up Study (NYC-SIGHT) Cluster-Randomized Clinical Trial: Subanalysis of Telemedicine Retinal Findings

Desiree R. Henriquez; Jason D. Horowitz; Rabia Karani; Jennifer O. Adeghate; Prakash Gorroochurn; Lisa Park; Qing Wang; Daniel Diamond; Noga Harizman; James D. Auran; Stefania C Maruri; Jeffrey M Liebmann; George A Cioffi; Tarun Sharma; Lisa A. Hark

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):4182.

ARVO Annual Meeting Abstract June 2022

Evaluation of a Deep Learning Model on a Real-World Clinical Glaucoma Dataset

Kaveri Thakoor; Ari Leshno; Sol La Bruna; Emmanouil Tsamis; Gustavo De Moraes; Paul Sajda; Noga Harizman; Jeffrey M Liebmann; George A Cioffi; Donald C Hood

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):2026 – A0467.

ARVO Annual Meeting Abstract June 2022

Manhattan Vision Screening and Follow-up Study: Epidemiologic characteristics of individuals referred to ophthalmology

Sitara Hirji; Weijie Violet Lin; Noga Harizman; Rabia Karani; Ives A. Valenzuela; David J. Doobin; Jason D Horowitz; Lisa Park; Qing Wang; Stefania Maruri; Daniel Diamond; Prakash Gorroochurn; Jeffrey M Liebmann; George A Cioffi; Lisa A Hark

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):3372 – A0159.

ARVO Annual Meeting Abstract June 2022

Comparison of Global and Hemifield Rates of Visual Field (VF) Progression in Glaucoma

Johnny Xiang Li; Carlos G DeMoraes; Noga Harizman; Ari Leshno; Qing Wang; George A Cioffi; Jeffrey M Liebmann

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):1274 – A0414.

ARVO Annual Meeting Abstract June 2022

Manhattan Vision Screening and Follow-up Study: Ocular Pathology in Telemedicine Images

Rabia Karani; Jason D Horowitz; Weijie Violet Lin; Sitara Hirji; Ives A. Valenzuela; Stefania Maruri; David J. Doobin; Tarun Sharma; Daniel Diamond; Prakash Gorroochurn; Lisa Park; Qing Wang; Noga Harizman; Jeffrey M Liebmann; George A Cioffi; Lisa A Hark

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):1403 – A0099.

ARVO Annual Meeting Abstract June 2022

Assessment of Alternative Tests for the ICD-10 Glaucoma Severity Score

Ari Leshno; Emmanouil (Manos) Tsamis; Noga Harizman; Qing Wang; Sol La Bruna; Anvit Rai; Carlos G DeMoraes; George A Cioffi; Jeffrey M Liebmann; Donald C Hood

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):826.

ARVO Annual Meeting Abstract June 2017

The Effect of Ologen ® Collagen Matrix (OCM) in Prevention of Intraocular Pressure spikes after Ahmed Glaucoma Valve Surgery (AGV-FP7): Intermediate results of a 2-Year Follow-up

Meliza Unson; Arkadiy Yadgarov; Robert Ritch; Tak Yee Tania Tai; Reena Garg; Noga Harizman

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):2114.

ARVO Annual Meeting Abstract April 2014

Comparison of Tono-Pen and Pneumotonometer Measurements from Scleral Locations with Intraocular Pressure Measurements from the Cornea

Tak Yee Tania Tai; Noga Harizman

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):129.

ARVO Annual Meeting Abstract March 2012

Sympathizing Intraocular Pressure Response to Contralateral Steroid Drop Usage

Benjamin B. Bert; Noga Harizman

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):5040.

NARROW

Content Type

Journal

Article Type

Topics

Tags

Specify Date Range

Can modifiable behavioral factors be identified to increase activation in patients with glaucoma?

Detecting Established Glaucoma Using OCT Alone: Utilizing an OCT Reading Center in a Real-World Clinical Setting

Manhattan Vision Screening and Follow-up Study (NYC-SIGHT) Cluster-Randomized Clinical Trial: Subanalysis of Falls Risk

A systematic OCT-based approach can improve ophthalmology residents’ performance in glaucoma detection

Manhattan Vision Screening and Follow-up Study (NYC-SIGHT) Cluster-Randomized Clinical Trial: Subanalysis of Glaucoma Suspect Findings

24-2 Visual Field Progression Rates Better Correlate with GCL than RNFL Rate of Change in Glaucoma

Manhattan Vision Screening and Follow-up Study (NYC-SIGHT) Cluster-Randomized Clinical Trial: Smartphone Ownership to Assess Digital Health Equity

Manhattan Vision Screening and Follow-up Study (NYC-SIGHT) Cluster-Randomized Clinical Trial: Subanalysis of Telemedicine Retinal Findings

Evaluation of a Deep Learning Model on a Real-World Clinical Glaucoma Dataset

Manhattan Vision Screening and Follow-up Study: Epidemiologic characteristics of individuals referred to ophthalmology

Comparison of Global and Hemifield Rates of Visual Field (VF) Progression in Glaucoma

Manhattan Vision Screening and Follow-up Study: Ocular Pathology in Telemedicine Images

Assessment of Alternative Tests for the ICD-10 Glaucoma Severity Score

The Effect of Ologen ® Collagen Matrix (OCM) in Prevention of Intraocular Pressure spikes after Ahmed Glaucoma Valve Surgery (AGV-FP7): Intermediate results of a 2-Year Follow-up

Comparison of Tono-Pen and Pneumotonometer Measurements from Scleral Locations with Intraocular Pressure Measurements from the Cornea

Sympathizing Intraocular Pressure Response to Contralateral Steroid Drop Usage

To View More...

You must be signed into an individual account to use this feature.